Alzheimer’s Doesn’t Care About Your Clinical Trials

***My son is getting married this weekend so I probably won’t have an email on Monday. I will resume next Wednesday. My apologies for that***

When it comes to neurodegenerative diseases like Alzheimer’s, most of us assume that progression is uniform—one-size-fits-all. But new research shows that’s far from the truth. A recent study published in PSYPost identified three distinct paths of cognitive decline in early Alzheimer’s disease, meaning that people can experience memory and thinking decline at very different rates.

What’s not that surprising is what this research highlights about the limitations of traditional clinical trials. Most trials for Alzheimer’s drugs, particularly those targeting beta-amyloid or tau proteins, focus almost exclusively on these proteins while largely ignoring lifestyle factors:

• Diet

• Exercise

• Sleep

• Stress, and

• Social engagement.

Previous clinical trials haven’t been overwhelmingly successful. In fact, some of the high-profile studies in the beta-amyloid space have come under scrutiny for fraudulent or misleading data, calling into question whether the approach itself is even addressing the real drivers of cognitive decline.

So, what does science actually say about lifestyle? Quite a lot, actually. Studies consistently show that regular physical activity can improve blood flow to the brain and support the growth of new neurons.

Diet—particularly the Mediterranean or MIND diets (I’m more of a fan of the Keto or carnivore diet as you probably know), rich in vegetables, fish, nuts, and olive oil—is linked to slower cognitive decline.

Quality sleep allows the brain to clear toxic proteins, including beta-amyloid.

And managing stress through meditation, social connection, or mindfulness practices reduces inflammation and protects brain cells.

The exciting takeaway is that, while genetics and age certainly play a role, how we live our daily lives can significantly influence the trajectory of cognitive decline. Some people with early Alzheimer’s may progress slowly for years, potentially because they engage in protective lifestyle habits, while others decline faster when lifestyle factors are neglected. Unfortunately, most drug trials don’t account for this variability, which may be why promising drugs often fail in real-world applications.

The message here is empowering: even in the face of neurodegenerative disease, we have tools at our disposal that can make a measurable difference.

Adopting healthier lifestyle habits isn’t just about preventing disease—it may also help slow progression if cognitive decline has already begun.

In short, while the science around proteins and Alzheimer’s continues to evolve (and sometimes stumble), the lifestyle choices we make today are proven, tangible ways to support brain health. Exercise, eat well, sleep deeply, reduce stress, and stay socially engaged—these aren’t just recommendations; they’re evidence-backed strategies that can help shape the path your brain takes.

Your brain may be more resilient than you think, and what you do every day matters more than a single drug.